Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
84.22
-0.42 (-0.50%)
Dec 20, 2024, 4:00 PM EST - Market closed
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $5.98 billion as of December 20, 2024. Its market cap has increased by 34.89% in one year.
Market Cap
5.98B
Enterprise Value
4.82B
1-Year Change
34.89%
Ranking
Category
Stock Price
$84.22
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $5.98B, an increase of 651.80%. That is a compound annual growth rate of 81.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 5.98B | 29.84% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bausch + Lomb | 6.34B |
| Waystar Holding | 6.34B |
| Legend Biotech | 6.25B |
| Lantheus Holdings | 6.21B |
| Grifols | 5.99B |
| Halozyme Therapeutics | 5.97B |
| Cytokinetics | 5.77B |
| Elanco Animal Health | 5.75B |